Companies /Industrials

Emerson Electric Company

NYSE: EMR Specialty Industrial Machinery
$150.07
▲ $1.09 (+0.73%) today
Markets open · 4:05pm ET

Q3 2026 Earnings

Reported Aug 4, 2026, 4:05pm ET · SEC source
$1.71
Beat +1.97%
EPS · est. $1.68
$4.9B
Beat +1.46%
Revenue · est. $4.8B
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−3%0+3%Aug 4Aug 5report 4:05pm ETearnings−0.0%+4.4%
−3%0+3%Aug 4Aug 5earnings−0.0%+4.4%
EMR +4.4%S&P 500 −0.0%
−3%0+3%Aug 4Aug 5report 4:05pm ETearnings−0.8%+4.4%
−3%0+3%Aug 4Aug 5earnings−0.8%+4.4%
EMR +4.4%NASDAQ −0.8%
0+3%+6%Aug 3Aug 12report 4:05pm ETearnings−0.0%+5.9%
0+3%+6%Aug 3Aug 12earnings−0.0%+5.9%
EMR +5.9%S&P 500 −0.0%
−3%0+3%+6%Aug 3Aug 12report 4:05pm ETearnings+0.0%+5.9%
−3%0+3%+6%Aug 3Aug 12earnings+0.0%+5.9%
EMR +5.9%NASDAQ +0.0%
+2.29%
Day of report
−3.42%
Next session
+0.82%
One week

Did EMR Beat Earnings? Q3 2026 Results

Emerson Electric posted a clean beat across the board in its fiscal third quarter ended June 30, 2026, extending its EPS consensus beat streak to five consecutive quarters as the industrial automation giant reported adjusted earnings of $1.71 per share, ahead of the $1.68 consensus by 1.97%, on revenue of $4.87 billion that topped estimates by 1.46% and grew 7.0% year over year. The primary engine behind the quarter was Emerson's Software & Systems segment, which delivered 11% underlying sales growth to $1.64 billion, with Test & Measurement alone surging 23% to $445.00 million, reflecting accelerating demand for automation and control infrastructure. Adjusted EBITA margins expanded to 26.7%, while free cash flow climbed 36% to $1.32 billion, giving management the confidence to raise its full-year fiscal 2026 adjusted EPS outlook to approximately $6.55 and guide fourth-quarter adjusted EPS to approximately $1.85, with analysts maintaining a broadly constructive stance on the stock heading into fiscal 2027.

Key Takeaways
  • Underlying orders grew 7%, led by Software & Systems and broad-based growth in North America and Asia
  • Software & Systems segment drove 11% sales growth with Test & Measurement up 23%
  • Adjusted segment EBITA margin expanded 140 basis points to 28.5%
  • Operating cash flow increased 34% to $1,425 million
  • Pretax earnings margin expanded 270 basis points to 18.8%

“Emerson had an outstanding third quarter with sales, margin expansion, earnings and cash flow all exceeding expectations. Demand was robust, with underlying orders up 7%, led by Software & Systems and broad-based growth in North America and Asia. The conflict in the Middle East remains fluid, and I am proud of our team's ability to deliver results and support our customers around the world.”

Emerson Electric CEO, on the earnings call

Forward Guidance & Outlook

Emerson raised its full-year fiscal 2026 guidance. The company now expects net sales growth of approximately 5% and underlying sales growth of approximately 3.5%. Full-year adjusted EPS is guided to approximately $6.55, with GAAP EPS of approximately $4.89. Q4 2026 guidance calls for approximately 5% net and underlying sales growth, with adjusted EPS of approximately $1.85 and GAAP EPS of approximately $1.45. Full-year operating cash flow is expected at approximately $4.1 billion and free cash flow at approximately $3.6 billion. The company plans to return approximately $2.2 billion to shareholders through approximately $1 billion in share repurchases and approximately $1.2 billion in dividends.

EMR YoY Financials

Q3 2026 vs Q3 2025 · SEC filings Q3 2025 Q3 2026
$0$2.0B$4.0B$4.6B$4.9BRevenue$2.4B$2.7BGross Profit$908.0M$1.0BOperating Income$586.0M$718.0MNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

EMR Revenue by Segment

Intelligent Devices$2.7B+6.0%
Software & Systems$1.6B+11.0%
Final Control$1.6B+4.0%
Control Systems & Software$1.2B+7.0%
Measurement & Analytical
Sensors$1.1B+8.0%
Discrete Automation
Safety & Productivity$552.0M+3.0%

Figures from SEC filings and company reports. Not investment advice.